首页|SCr、Cys-C联合尿β2-MG对乙肝肝硬化失代偿期患者肾损伤的诊断价值

SCr、Cys-C联合尿β2-MG对乙肝肝硬化失代偿期患者肾损伤的诊断价值

扫码查看
目的 探索联合检测血清肌酐(SCr)、血清胱抑素C(Cys-C)和尿β2-微球蛋白(β2-MG)水平在评估乙肝肝硬化失代偿期患者早期肾损伤中的诊断价值,为临床诊疗提供参考.方法 回顾性分析2021年1月-2023年1月在中山大学附属第三医院治疗的乙肝肝硬化失代偿期患者,根据患者病史资料、临床表现、并发症、肾小球滤过率(eGFR)将患者分为肾损伤组[eGFR<90 mL/(min·1.73 m2)]50例和非肾损伤组[eGFR≥90 mL/(min·1.73 m2)]50例,另选取同期体检的健康人员50名为对照组,单因素分析相关因素在3组人员中的差异,采用Pearson相关分析3组中SCr、Cys-C以及尿β2-MG与eGFR的相关性,采用多因素logistic回归分析构建诊断模型,并绘制受试者工作特征(ROC)曲线以评估联合检测因子的诊断效能.结果 肾损伤组的SCr、Cys-C、尿β2-MG水平均显著高于非肾损伤组和对照组,差异均有统计学意义(F=38.789、61.999、47.124,P均<0.001).在肾损伤患者中,SCr、Cys-C、尿β2-MG均与eGFR成负相关(r=-0.895、-0.893、-0.834,P均<0.05).三者联合检测的ROC曲线下面积(AUC)最大(AUC=0.997,P<0.001),高于单一因素 SCr(AUC=0.952,P<0.001)、Cys-C(AUC=0.966,P<0.001)和尿 β2-MG(AUC=0.924,P<0.001),其预测患者病情的灵敏度和特异度分别为100%、96%.结论 SCr、Cys-C和尿β2-MG联合检测可作为乙肝肝硬化失代偿期肾损伤的相关筛查指标,对乙肝肝硬化继发肾损伤的检测效能优于单一指标.
The diagnostic value of SCr and Cys-C combined with urinary β2-MG on renal injury in patients with hepatitis B cirrhosis in decompensated stage
Objective To analyze the diagnostic value of serum creatinine(Scr)and serum cystatin C(Cys-C)combined with urinary beta-2-microglobulin(β2-MG)in assessing early kidney injury caused by hepatitis B cirrhosis in the decompensated stage.Methods A retrospective study of patients with hepatitis B cirrhosis in the decompensated stage treated in the Third Affiliated Hospital of Sun Yat-sen University from January 2021 to January 2023.According to patient history,clinical presentation,complications,and estimated glomerular filtration rate(eGFR),the patients were divided into 50 patients in the renal injury group[eGFR<90 mL/(min·1.73 m2)]and 50 patients in the non-renal injury group[eGFR≥90 mL/(min·1.73 m2)].Another 50 healthy person were selected as the healthy group.One-way ANOVA was used to analyze the differences of the relevant factors among the three groups;Pearson correlation was used to analyze the correlation between SCr,Cys-C,and urinary β2-MG and eGFR in the three groups;multifactorial logistic regression analysis was used to construct the diagnostic model,and receiver operating characteristic(ROC)curves were plotted to assess the diagnostic efficacy of the combined test factors.Results The SCr,Cys-C and urinary β2-MG in renal injury group were significantly higher than those in non-renal injury group and healthy group(F=38.789,61.999,47.124;all P<0.001).In renal injury group,SCr,Cys-C and urinary β2-MG were negatively correlated with the eGFR(r=-0.895,-0.893,-0.834;all P<0.05).Their combined detection area under the ROC curve(AUC)was the largest(AUC=0.997,P<0.001),higher than that of the single factor SCr(AUC=0.952,P<0.001),Cys-C(AUC=0.966,P<0.001)and urinary β2-MG(AUC=0.924,P<0.001),and the sensitivity and specificity were 100%and 96%,respectively.Conclusion SCr,Cys-C and urinary β2-MG combined detection can be used as a relevant screening indicator for kidney injury in hepatitis B cirrhosis in decompensated stage,and was better than a single index.

Hepatitis B cirrhosisDecompensated stageRenal injurySerum creatinineSerum cystatin CUrinary β2-MG

丁璐、刘胜、胡波

展开 >

中山大学附属第三医院检验科,广东 广州 510000

乙肝肝硬化 失代偿期 肾损伤 血清肌酐 血清胱抑素C 尿β2-微球蛋白

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(11)